# Study on Risk Factors and Prognosis of MASLD

> **NCT07433205** · — · COMPLETED · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 922 (actual)

## Conditions studied

- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07433205
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 922 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433205, "Study on Risk Factors and Prognosis of MASLD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07433205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*